Fox Run Management L.L.C. Acquires Shares of 3,425 Colgate-Palmolive Company $CL

Key Points

• Fox Run Management L.L.C. has made a new investment of **$321,000** in **Colgate-Palmolive Company**, acquiring **3,425 shares** during the first quarter.
• Analyst ratings are mixed, with UBS Group lowering their target price to **$106.00** while maintaining a "buy" rating, and Citigroup decreasing theirs to **$105.00** with a "buy" rating as well.
• Colgate-Palmolive recently reported earnings of **$0.92 per share**, exceeding expectations and driving a revenue growth of **1.0%** year-over-year, with the company declaring a **$0.52 quarterly dividend**.

Fox Run Management L.L.C. acquired a new stake in Colgate-Palmolive Company (NYSE:CL - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,425 shares of the company's stock, valued at approximately $321,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Westend Capital Management LLC increased its stake in shares of Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. bought a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $31,000. Accredited Wealth Management LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $34,000. Finally, Y.D. More Investments Ltd bought a new stake in Colgate-Palmolive in the first quarter valued at approximately $37,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.6%

Shares of CL traded down $0.5010 during trading hours on Friday, reaching $85.7790. The stock had a trading volume of 4,087,413 shares, compared to its average volume of 5,056,872. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30. The firm has a 50-day simple moving average of $87.60 and a 200 day simple moving average of $89.93. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market capitalization of $69.33 billion, a price-to-earnings ratio of 24.10, a P/E/G ratio of 4.47 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. During the same period last year, the business earned $0.91 EPS. Colgate-Palmolive's quarterly revenue was up 1.0% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Wall Street Analyst Weigh In

Several analysts recently commented on CL shares. Morgan Stanley reduced their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday, August 4th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Barclays raised their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.